CIR Expert Panel To Prioritize Cannabidiol Review In 2024 At FDA’s Request

Cosmetic Ingredient Review’s independent experts note that CBD use in cosmetic products has increased since FDA first asked them to prioritize its review in 2020.

Conceptual image of CBD legalization and use.

More from Ingredients & Safety

More from HBW Insight